Drug Patent Watch
APRIL 14, 2024
Annual Drug Patent Expirations for DEXILANT+SOLUTAB Dexilant Solutab is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are six patents protecting this drug.
Alta Sciences
APRIL 14, 2024
Risk-Based Auditing and its Application to GLP Computerized System Validation Procedures iianiro Sun, 04/14/2024 - 20:49 URL [link] Date of publication April 11, 2024 Category Poster Weight 1
Drug Patent Watch
APRIL 14, 2024
DEXILANT (dexlansoprazole) Takeda pharms usa Patent: 8,722,084 Expiration: Apr 15, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.
Alta Sciences
APRIL 14, 2024
Collaborating for Success Tips for Improving Partnerships Between QA and Clinical Operations at Your Sitei iianiro Sun, 04/14/2024 - 21:17 Image SQA_2024_Collaborations_for_Success_0.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
APRIL 14, 2024
Annual Drug Patent Expirations for QVAR+REDIHALER Qvar Redihaler is a drug marketed by Norton Waterford and is included in one NDA. It is available from three suppliers.
Drug Patent Watch
APRIL 14, 2024
Annual Drug Patent Expirations for DEXILANT Dexilant is a drug marketed by Takeda Pharms Usa and is included in two NDAs. It is available from four suppliers.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drug Patent Watch
APRIL 14, 2024
Annual Drug Patent Expirations for TAGRISSO Tagrisso is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier.
Drug Patent Watch
APRIL 14, 2024
Annual Drug Patent Expirations for EPRONTIA Eprontia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier.
Drug Patent Watch
APRIL 14, 2024
This chart shows the pharmaceutical companies with the most patents in New Zealand.
Expert insights. Personalized for you.
59 
Let's personalize your content